About Cytochrome P450 2C18
Cytochrome P450 2C18 (CYP2C18) is a protein
from Homo sapiens identified by UniProt accession
P33260, 490 residues long.
MolForge cross-references it against 0 known binders and
69 disease associations.
Target properties
| Protein name | Cytochrome P450 2C18 |
| UniProt accession | P33260 |
| Gene | CYP2C18 |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (69)
Diseases linked to this target (Open Targets).
- response to anticoagulant · score 0.37
- clopidogrel metabolite measurement · score 0.36
- neurodegenerative disease · score 0.30
- bilirubin measurement · score 0.30
- alkaline phosphatase measurement · score 0.29
- platelet reactivity measurement · score 0.24
- response to clopidogrel · score 0.24
- unipolar depression · score 0.21
- response to selective serotonin reuptake inhibitor · score 0.21
- blood metabolite measurement · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P33260-F1 | alphafold | PREDICTED | 93.84 | — |
Amino-acid sequence (490 residues)
MDPAVALVLC LSCLFLLSLW RQSSGRGRLP SGPTPLPIIG NILQLDVKDM SKSLTNFSKV YGPVFTVYFG LKPIVVLHGY EAVKEALIDH GEEFSGRGSF PVAEKVNKGL GILFSNGKRW KEIRRFCLMT LRNFGMGKRS IEDRVQEEAR CLVEELRKTN ASPCDPTFIL GCAPCNVICS VIFHDRFDYK DQRFLNLMEK FNENLRILSS PWIQVCNNFP ALIDYLPGSH NKIAENFAYI KSYVLERIKE HQESLDMNSA RDFIDCFLIK MEQEKHNQQS EFTVESLIAT VTDMFGAGTE TTSTTLRYGL LLLLKYPEVT AKVQEEIECV VGRNRSPCMQ DRSHMPYTDA VVHEIQRYID LLPTNLPHAV TCDVKFKNYL IPKGTTIITS LTSVLHNDKE FPNPEMFDPG HFLDKSGNFK KSDYFMPFSA GKRMCMGEGL ARMELFLFLT TILQNFNLKS QVDPKDIDIT PIANAFGRVP PLYQLCFIPV
Explore Cytochrome P450 2C18 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets